Free Trial

Deciphera Pharmaceuticals (DCPH) Earnings Date, Estimates & Call Transcripts

$25.59
0.00 (0.00%)
(As of 07/12/2024)

Earnings Summary

Upcoming
Earnings Date
Aug. 14Estimated
Actual EPS
(May. 10)
-$0.52 Beat By $0.03
Consensus EPS
(May. 10)
-$0.55
Skip Charts & View Estimated and Actual Earnings Data

DCPH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DCPH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Deciphera Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243($0.63)($0.50)($0.59) 
Q2 20243($0.66)($0.49)($0.59) 
Q3 20243($0.65)($0.48)($0.58) 
Q4 20243($0.64)($0.48)($0.56) 
FY 202412($2.58)($1.95)($2.32) 
Q1 20251($0.57)($0.57)($0.57) 
Q2 20251($0.55)($0.55)($0.55) 
Q3 20251($0.49)($0.49)($0.49) 
Q4 20251($0.42)($0.42)($0.42) 
FY 20254($2.03)($2.03)($2.03) 
Q1 20261($0.38)($0.38)($0.38) 

DCPH Earnings Date and Information

Deciphera Pharmaceuticals last issued its earnings data on May 10th, 2024. The reported ($0.52) EPS for the quarter, beating the consensus estimate of ($0.55) by $0.03. The firm had revenue of $45 million for the quarter, compared to analysts' expectations of $45.99 million. Deciphera Pharmaceuticals has generated ($2.21) earnings per share over the last year (($2.21) diluted earnings per share). Earnings for Deciphera Pharmaceuticals are expected to grow in the coming year, from ($2.15) to ($1.77) per share. Deciphera Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.

Deciphera Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/14/2024
(Estimated)
------- 
5/10/2024Q1 2024($0.55)($0.52)+$0.03($0.52)$45.99 million$45.00 million
2/6/2024Q4 2023($0.58)($0.54)+$0.04($0.54)$45.93 million$48.30 million      
10/30/2023Q3 2023($0.61)($0.58)+$0.03($0.58)$39.66 million$43.31 million  
8/9/2023Q2 2023($0.62)($0.57)+$0.05($0.57)$36.09 million$38.30 million      
5/3/2023Q1 2023($0.60)($0.60)-($0.60)$35.50 million$33.45 million    
2/7/2023Q4 2022($0.57)($0.60)($0.03)($0.60)$35.88 million$36.40 million      
11/3/2022Q3 2022($0.57)($0.55)+$0.02($0.55)$33.29 million$35.97 million
8/4/2022Q2 2022($0.65)($0.60)+$0.05($0.60)$30.11 million$32.49 million      
5/4/2022Q1 2022($0.84)($0.80)+$0.04($0.80)$27.17 million$29.22 million      
2/8/2022Q4 2021($1.49)($1.51)($0.02)($1.51)$23.28 million$24.20 million    
11/2/2021Q3 2021($1.29)($1.37)($0.08)($1.37)$23.73 million$23.22 million    
8/3/2021Q2 2021($1.15)($1.21)($0.06)($1.21)$22.25 million$23.57 million    
5/4/2021Q1 2021($1.08)($1.06)+$0.02($1.06)$21.35 million$25.16 million  
2/8/2021Q4 2020($1.16)($1.10)+$0.06($1.10)$18.68 million$19.49 million  
11/5/2020Q3 2020($1.32)($1.13)+$0.19($1.13)$6.73 million$15.45 million    
8/4/2020Q2 2020($1.34)($1.20)+$0.14($1.20)$2.03 million$7.09 million    
5/5/2020Q1 2020($1.28)($1.36)($0.08)($1.36)$2.50 million$0.06 million    
3/9/2020Q4 2019($1.13)($1.31)($0.18)($1.31)$7.50 million-  
11/4/2019Q3($1.19)($1.28)($0.09)($1.28)$5.00 million-    
8/2/2019Q2 2019($1.1240)($0.56)+$0.5640($0.56)$20.00 million$25.00 million

Deciphera Pharmaceuticals Earnings - Frequently Asked Questions

When is Deciphera Pharmaceuticals's earnings date?

Deciphera Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on DCPH's earnings history.

Did Deciphera Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Deciphera Pharmaceuticals (NASDAQ:DCPH) reported ($0.52) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.55) by $0.03. Learn more on analysts' earnings estimate vs. DCPH's actual earnings.

How much revenue does Deciphera Pharmaceuticals generate each year?

Deciphera Pharmaceuticals (NASDAQ:DCPH) has a recorded annual revenue of $174.91 million.

How much profit does Deciphera Pharmaceuticals generate each year?

Deciphera Pharmaceuticals (NASDAQ:DCPH) has a recorded net income of -$194.94 million. DCPH has generated -$2.21 earnings per share over the last four quarters.

What is Deciphera Pharmaceuticals's EPS forecast for next year?

Deciphera Pharmaceuticals's earnings are expected to grow from ($2.15) per share to ($1.77) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:DCPH) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners